Subnormal tissue 3 alpha-androstanediol and androsterone in prostatic hyperplasia

Area of Science:

• Endocrinology
• Urology
• Biochemistry

Background:

• Benign prostatic hyperplasia (BPH) is a common condition in aging men.
• The role of androgens, including 3 alpha-androstanediol (3 alpha-diol) and 5 alpha-dihydrotestosterone (DHT), in BPH development is not fully understood.
• Enzymatic metabolism of androgens in prostatic tissue is critical for understanding BPH pathogenesis.

Purpose of the Study:

• To investigate the role of 3 alpha-diol in BPH development.
• To examine the equilibrium of enzymes metabolizing 3 alpha-diol in normal and hyperplastic prostate tissue.
• To determine androgen concentrations in normal and BPH human prostate glands.

Main Methods:

• Radioimmunoassay (RIA) was used to quantify endogenous concentrations of 3 alpha-diol, androsterone, and DHT.
• Androgens were extracted and purified using paper chromatography from normal and hyperplastic prostate tissues.
• Statistical analysis was performed to compare androgen levels and ratios between normal and BPH groups.

Main Results:

• Mean concentrations of 3 alpha-diol and androsterone were approximately one-third lower in BPH tissue compared to normal tissue.
• The ratio of DHT to 3 alpha-diol concentration was significantly higher in BPH (P < 0.005).
• No significant difference was found in the ratio of 3 alpha-diol to androsterone between normal and BPH tissues.

Conclusions:

• The study data do not support a causal relationship between 3 alpha-diol and BPH development.
• The results suggest that the enzymatic equilibrium favors DHT formation, which may be relevant to prostate growth in aging men.
• Further research into androgen metabolism and its role in prostate health is warranted.